tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BDRX Stock Latest News

Biodexa Pharmaceuticals Announces ADR Ratio Change
Company AnnouncementsBiodexa Pharmaceuticals Announces ADR Ratio Change
14h ago
6K
BDRX
Biodexa anounces ratio change on its ADR, effective date October24
PremiumThe Fly
Biodexa anounces ratio change on its ADR, effective date October24
15h ago
BDRX
ADR Ratio Change
PremiumPress Releases
ADR Ratio Change
15h ago
BDRX
Biodexa Pharmaceuticals Advances FAP Treatment
PremiumCompany Announcements
Biodexa Pharmaceuticals Advances FAP Treatment
4d ago
6K
BDRX
Biodexa Pharmaceuticals announces final match payment with respect to $17M grant
PremiumThe Fly
Biodexa Pharmaceuticals announces final match payment with respect to $17M grant
4d ago
BDRX
Biodexa Pharmaceuticals Confronts Nasdaq Delisting
PremiumCompany AnnouncementsBiodexa Pharmaceuticals Confronts Nasdaq Delisting
21d ago
6K
BDRX
Receipt of Nasdaq Delisting Determination – Plans to Appeal
Premium
Press Releases
Receipt of Nasdaq Delisting Determination – Plans to Appeal
21d ago
BDRX
Biodexa Pharmaceuticals files to sell 4.35B ordinary shares for holders
Premium
The Fly
Biodexa Pharmaceuticals files to sell 4.35B ordinary shares for holders
1M ago
BDRX
Biodexa Pharmaceuticals Secures $5M Funding
PremiumCompany Announcements
Biodexa Pharmaceuticals Secures $5M Funding
2M ago
6K
BDRX
Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
PremiumPress Releases
Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
2M ago
BDRX
Biodexa Pharmaceuticals Unveils Series J Warrant
PremiumCompany Announcements
Biodexa Pharmaceuticals Unveils Series J Warrant
2M ago
6K
BDRX
Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
PremiumPress Releases
Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
2M ago
BDRX
Biodexa Pharmaceuticals prices $5M registered direct offering at 94c per share
PremiumThe FlyBiodexa Pharmaceuticals prices $5M registered direct offering at 94c per share
2M ago
BDRX
Biodexa’s Diabetes Drug Enters Phase 2a Studies
Premium
Company Announcements
Biodexa’s Diabetes Drug Enters Phase 2a Studies
2M ago
6K
BDRX
Biodexa Pharmaceuticals announces Phase 2a study of tolimidone in T1D
Premium
The Fly
Biodexa Pharmaceuticals announces Phase 2a study of tolimidone in T1D
2M ago
BDRX
Biodexa announces additional results of Phase 2 trial of eRapa
PremiumThe Fly
Biodexa announces additional results of Phase 2 trial of eRapa
2M ago
BDRX
Biodexa Pharma Announces Executive Departure
PremiumCompany Announcements
Biodexa Pharma Announces Executive Departure
3M ago
6K
BDRX
Biodexa’s MTX110 Shows Promise in Brain Cancer Trial
PremiumCompany Announcements
Biodexa’s MTX110 Shows Promise in Brain Cancer Trial
3M ago
6K
BDRX
Biodexa Pharmaceuticals’ MTX110 increases survival in DMG brain cancer study
PremiumThe Fly
Biodexa Pharmaceuticals’ MTX110 increases survival in DMG brain cancer study
3M ago
BDRX
Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024
PremiumPress ReleasesPositive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024
3M ago
BDRX
Biodexa’s eRapa™ Shows Promise in FAP Trial
Premium
Company Announcements
Biodexa’s eRapa™ Shows Promise in FAP Trial
3M ago
6K
BDRX
Biodexa announces eRapa data at 12 months for FAP
Premium
The Fly
Biodexa announces eRapa data at 12 months for FAP
3M ago
BDRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >